Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-07-25 Sale |
2022-07-27 6:20 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
75,100 | $43.25 | $3,248,199 | 1,002,845 (Indirect Direct) |
View |
| 2022-07-25 Sale |
2022-07-27 6:17 pm |
Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments |
23,334 | $43.18 | $1,007,446 | 19,020 (Indirect Direct) |
View |
| 2022-06-29 Sale |
2022-06-29 6:02 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
30,000 | $42.17 | $1,265,238 | 521,899 (Indirect Direct) |
View |
| 2022-06-24 Sale |
2022-06-24 5:19 pm |
Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments |
23,333 | $43.19 | $1,007,694 | 42,354 (Indirect Direct) |
View |
| 2022-06-08 Sale |
2022-06-10 5:13 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer |
100,000 | $41.56 | $4,155,900 | 945,830 (Indirect) |
View |
| 2022-05-27 Sale |
2022-05-31 5:23 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer |
75,000 | $41.08 | $3,081,008 | 1,045,830 (Indirect) |
View |
| 2022-05-26 Sale |
2022-05-31 5:19 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
100,000 | $40.29 | $4,029,091 | 1,446,831 (Indirect Direct) |
View |
| 2022-05-23 Sale |
2022-05-25 5:10 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
100,000 | $40.27 | $4,026,770 | 1,546,831 (Indirect Direct) |
View |
| 2022-05-19 Sale |
2022-05-23 4:57 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer |
75,000 | $40.44 | $3,033,128 | 1,120,830 (Indirect) |
View |
| 2022-05-19 Sale |
2022-05-23 4:55 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
150,000 | $39.42 | $5,913,306 | 551,899 (Indirect Direct) |
View |
| 2022-05-16 Sale |
2022-05-16 7:14 pm |
Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments |
23,333 | $39.85 | $929,836 | 65,687 (Indirect Direct) |
View |
| 2022-03-29 Sale |
2022-03-30 6:46 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
60,000 | $38.59 | $2,315,322 | 701,899 (Indirect Direct) |
View |
| 2022-03-18 Sale |
2022-03-21 6:20 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
169,089 | $39.43 | $6,667,521 | 2,582,164 (Indirect Direct) |
View |
| 2022-02-24 Purchase |
2022-02-25 7:21 pm |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
32,500 | $37.49 | $1,218,373 | 76,136 (Indirect Direct) |
View |
| 2021-12-28 Sale |
2021-12-30 6:07 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
184,448 | $40.12 | $7,400,767 | 2,591,702 (Indirect Direct) |
View |
| 2021-11-16 Sale |
2021-11-18 7:18 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
250,000 | $42.39 | $10,596,693 | 1,593,556 (Indirect Direct) |
View |
| 2021-11-16 Sale |
2021-11-18 7:15 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
214,389 | $42.34 | $9,076,492 | 3,680,406 (Indirect Direct) |
View |
| 2021-09-28 Sale |
2021-09-30 3:56 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
128,425 | $36.51 | $4,688,288 | 3,892,800 (Indirect Direct) |
View |
| 2021-07-26 Sale |
2021-07-27 5:29 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
13,362 | $39.78 | $531,532 | 1,300,960 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-07-08 Option Award |
2022-07-11 7:02 pm |
N/A N/A |
Royalty Pharma plc | RPRX | HODGSON DAVID C Director |
2,346 | $0 | 8,674 (Direct) |
View |
| 2022-06-30 Option Award |
2022-06-30 06:55 am |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
903 | $41.52 | 31,925 (Direct) |
View |
| 2022-06-30 Option Award |
2022-06-30 06:51 am |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
903 | $41.52 | 84,331 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-24 4:59 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Norden Gregory Director |
6,328 | $0 | 56,698 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-24 4:59 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Engelbert Catherine M. Director |
6,328 | $0 | 25,464 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-24 4:57 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
6,328 | $0 | 31,022 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-24 4:57 pm |
N/A N/A |
Royalty Pharma plc | RPRX | LOVE TED W Director |
6,328 | $0 | 29,194 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-24 4:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | DESOUZA ERROL B Director |
6,328 | $0 | 56,698 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-24 4:53 pm |
N/A N/A |
Royalty Pharma plc | RPRX | HODGSON DAVID C Director |
6,328 | $0 | 6,328 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-24 4:49 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
6,328 | $0 | 83,428 (Direct) |
View |
| 2022-05-11 Conversion |
2022-05-11 5:20 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments |
77,000 | $0 | 294,614 (Direct) |
View |
| 2020-06-16 Conversion |
2022-04-15 6:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
1,198,821 | $0 | 36,641,176 (Indirect) |
View |
| 2021-03-23 Other |
2022-04-15 6:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
917,322 | $0 | 36,641,176 (Indirect) |
View |
| 2022-03-31 Option Award |
2022-04-01 6:29 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
964 | $38.87 | 77,100 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-01 6:26 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
964 | $38.87 | 24,694 (Direct) |
View |
| 2022-03-17 Other |
2022-03-21 6:20 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
1,905,452 | $0 | 2,582,164 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-03 5:35 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
958 | $39.11 | 43,636 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-03 5:29 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
958 | $39.11 | 23,730 (Direct) |
View |
| 2021-12-28 Other |
2021-12-30 6:07 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
1,310,902 | $0 | 2,591,702 (Direct) |
View |
| 2021-09-10 Gift |
2021-12-30 6:03 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
5,128 | $0 | 481,270 (Indirect) |
View |
| 2021-09-10 Gift |
2021-11-18 7:18 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
1,282 | $0 | 1,593,556 (Direct) |
View |
| 2021-11-16 Other |
2021-11-18 7:15 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
1,927,363 | $0 | 3,680,406 (Direct) |
View |
| 2021-09-29 Other |
2021-09-30 3:56 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
952,701 | $0 | 3,892,800 (Direct) |
View |
| 2021-09-10 Gift |
2021-09-30 3:56 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
7,692 | $0 | 3,892,800 (Direct) |
View |
| 2021-09-30 Option Award |
2021-09-30 3:17 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
992 | $37.8 | 42,678 (Direct) |
View |
| 2021-09-30 Option Award |
2021-09-30 3:12 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
992 | $37.8 | 22,772 (Direct) |
View |